HoPE (Hospice Preparation and Education)
Withdrawn before enrolling · Not applicable
Conditions studied: Hospice Care
In brief
The investigator will conduct a two-site, randomized, controlled study of the HoPE (Hospice Preparation and Education) web-based tool versus usual care to assess: Technology usability (primary), study feasibility (secondary), user acceptability (secondary), and hospice service conversion rate (exploratory). Technology usability will be assessed through a one-time quantitative survey using established instruments. Study feasibility and user accessibility will be assessed through trial enrollment and retention alongside analytics assessing tool usage (e.g. time spent on each page of the website). Conversion rate is the percent of patients introduced to hospice who eventually enroll. The investigators will evaluate in an exploratory manner the differential effect of HoPE versus usual care.
Key facts
- Study ID
- NCT04410627
- Run by
- Duke University
- People needed
- 0
- Starts
- 2022-06-01
- Expected to finish
- 2022-12-31
- Last updated by the study team
- 2022-03-18
Who can join
Age: 21 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Eligible for and referral made for home hospice services (Note: this excludes home palliative care, home infusion, home nursing, home physical therapy, and bridge services)
- Aged between 21 and 89
- Capacity to give consent
- Ability to speak and understand English
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States
- WakeMed Health & Hospitals — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.